Guy Georges

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Molecular Dynamics Simulations

Randomized Controlled Trial

Hyaluronic Acid

Top Venues

Nucleic acids research

Protein engineering, design & selection : PEDS

This page only lists publications with an associated author ORCID identifier.

Publications

Johannes Sam, Thomas Hofer, Christine Kuettel, Christina Claus, Jenny Thom, Sylvia Herter, Guy Georges, Koorosh Korfi, Martin Lechmann, Miro Julian Eigenmann, Daniel Marbach, Candice Jamois, Katharina Lechner, Sreenath M Krishnan, Brenda Gaillard, Joana Marinho, Sven Kronenberg, Leo Kunz, Sabine Wilson, Stefanie Briner, Samuel Gebhardt, Ahmet Varol, Birte Appelt, Valeria Nicolini, Dario Speziale, Miriam Bez, Esther Bommer, Jan Eckmann, Carina Hage, Florian Limani, Silvia Jenni, Anne Schoenle, Marine Le Clech, Jean-Baptiste Pierre Vallier, Sara Colombetti, Marina Bacac, Stephan Gasser, Christiane Neumann, Pablo Umaña
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy. Blood 143 (21) (2024)
Johannes Sam, Thomas Hofer, Christine Kuettel, Christina Claus, Jenny Thom, Sylvia Herter, Guy Georges, Koorosh Korfi, Martin Lechmann, Miro Julian Eigenmann, Daniel Marbach, Candice Jamois, Katharina Lechner, Sreenath M Krishnan, Brenda Gaillard, Joana Marinho, Sven Kronenberg, Leo Kunz, Sabine Wilson, Stefanie Briner, Samuel Gebhardt, Ahmet Varol, Birte Appelt, Valeria Nicolini, Dario Speziale, Miriam Bez, Esther Bommer, Jan Eckmann, Carina Hage, Florian Limani, Silvia Jenni, Anne Schoenle, Marine Le Clech, Jean-Baptiste Pierre Vallier, Sara Colombetti, Marina Bacac, Stephan Gasser, Christiane Neumann, Pablo Umaña
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy. Blood 143 (21) (2024)
Johannes Sam, Thomas Hofer, Christine Kuettel, Christina Claus, Jenny Thom, Sylvia Herter, Guy Georges, Koorosh Korfi, Martin Lechmann, Miro Julian Eigenmann, Daniel Marbach, Candice Jamois, Katharina Lechner, Sreenath M Krishnan, Brenda Gaillard, Joana Marinho, Sven Kronenberg, Leo Kunz, Sabine Wilson, Stefanie Briner, Samuel Gebhardt, Ahmet Varol, Birte Appelt, Valeria Nicolini, Dario Speziale, Miriam Bez, Esther Bommer, Jan Eckmann, Carina Hage, Florian Limani, Silvia Jenni, Anne Schoenle, Marine Le Clech, Jean-Baptiste Pierre Vallier, Sara Colombetti, Marina Bacac, Stephan Gasser, Christiane Neumann, Pablo Umaña
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy. Blood 143 (21) (2024)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Brennan Abanades, Tobias H Olsen, Matthew I J Raybould, Broncio Aguilar-Sanjuan, Wing Ki Wong, Guy Georges, Alexander Bujotzek, Charlotte M Deane
The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures. Nucleic acids research (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Nancy D Pomarici, Monica L Fernández-Quintero, Patrick K Quoika, Franz Waibl, Alexander Bujotzek, Guy Georges, Klaus Roman Liedl
Bispecific antibodies-effects of point mutations on CH3-CH3 Interface stability. Protein engineering, design & selection : PEDS (2022)
Monica L I Fernández-Quintero, Guy Georges, Janos M Varga, Klaus Roman Liedl
Ensembles in solution as a new paradigm for antibody structure prediction and design. mAbs 13 (1) (2021)
Wing Ki Wong, Sarah A Robinson, Alexander Bujotzek, Guy Georges, Alan P Lewis, Jiye Shi, James Snowden, Bruck Taddese, Charlotte M Deane
Ab-Ligity: identifying sequence-dissimilar antibodies that bind to the same epitope. mAbs 13 (1) (2021)
Monica L I Fernández-Quintero, Johannes Kraml, Guy Georges, Klaus Roman Liedl
CDR-H3 loop ensemble in solution - conformational selection upon antibody binding. mAbs 11 (6) (2019)